Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IMPACT is an immunomodulating oral nutritional supplement (ONS) produced by Nestlé Health Science, specifically formulated as a medical food for the dietary management of patients undergoing major surgery or facing clinical challenges like trauma or burns. The formula contains a unique blend of immunonutrients, including arginine, glutamine, omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid), nucleotides, and antioxidants (vitamins C and E). These components work synergistically to modulate the immune response, reduce systemic inflammation, and support tissue repair and protein synthesis. In clinical settings, such as the Phase 4 trials conducted at Stanley Dudrick's Memorial Hospital, IMPACT is administered preoperatively to patients with gastrointestinal cancer to reduce the incidence of postoperative infectious complications and decrease the length of hospital stay.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IMPACT.